{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:27:55Z","timestamp":1791138475468,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T00:00:00Z","timestamp":1154908800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Respiratory syncytial virus (RSV) is the most common cause of acute bronchiolitis in infants and the elderly. Furthermore, epidemiological data suggest that RSV infection during infancy is a potent trigger of subsequent wheeze and asthma development. However, the mechanism by which RSV contributes to asthma is complex and remains largely unknown. A recent study indicates that the age of initial RSV infection is a key factor in determining airway response to RSV rechallenge. We hypothesized that severe RSV infection during neonatal development significantly alters lung structure and the pulmonary immune micro-environment; and thus, neonatal RSV infection is crucial in the development of or predisposition to allergic inflammatory diseases such as asthma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To investigate this hypothesis the present study was conducted in a neonatal mouse model of RSV-induced pulmonary inflammation and airway dysfunction. Seven-day-old mice were infected with RSV (2 \u00d7 10<jats:sup>5<\/jats:sup>TCID<jats:sub>50<\/jats:sub>\/g body weight) and allowed to mature to adulthood. To determine if neonatal RSV infection predisposed adult animals to enhanced pathophysiological responses to allergens, these mice were then sensitized and challenged with ovalbumin. Various endpoints including lung function, histopathology, cytokine production, and cellularity in bronchoalveolar lavage were examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>RSV infection in neonates alone led to inflammatory airway disease characterized by airway hyperreactivity, peribronchial and perivascular inflammation, and subepithelial fibrosis in adults. If early RSV infection was followed by allergen exposure, this pulmonary phenotype was exacerbated. The initial response to neonatal RSV infection resulted in increased TNF-\u03b1 levels in bronchoalveolar lavage. Interestingly, increased levels of IL-13 and mucus hyperproduction were observed almost three months after the initial infection with RSV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Neonatal RSV exposure results in long term pulmonary inflammation and exacerbates allergic airways disease. The early increase in TNF-\u03b1 in the bronchoalveolar lavage implicates this inflammatory cytokine in orchestrating these events. Finally, the data presented emphasize IL-13 and TNF-\u03b1 as potential therapeutic targets for treating RSV induced-asthma.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1465-9921-7-107","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T06:58:50Z","timestamp":1155020330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Exposure of neonates to Respiratory Syncytial Virus is critical in determining subsequent airway response in adults"],"prefix":"10.1186","volume":"7","author":[{"given":"Dahui","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Becnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ripple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephania A","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,7]]},"reference":[{"issue":"3","key":"498_CR1_498","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","volume":"18","author":"PJ Openshaw","year":"2005","unstructured":"Openshaw PJ, Tregoning JS: Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 2005,18(3):541\u2013555.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"498_CR2_498","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/00006454-200207000-00005","volume":"21","author":"S Leader","year":"2002","unstructured":"Leader S, Kohlhase K: Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002,21(7):629\u2013632.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"498_CR3_498","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.74.1.1","volume":"74","author":"KM McConnochie","year":"1984","unstructured":"McConnochie KM, Roghmann KJ: Bronchiolitis as a possible cause of wheezing in childhood: new evidence. Pediatrics 1984,74(1):1\u201310.","journal-title":"Pediatrics"},{"issue":"6330","key":"498_CR4_498","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/bmj.284.6330.1665","volume":"284","author":"CR Pullan","year":"1982","unstructured":"Pullan CR, Hey EN: Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) 1982,284(6330):1665\u20131669.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6104","key":"498_CR5_498","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/bmj.1.6104.11","volume":"1","author":"DG Sims","year":"1978","unstructured":"Sims DG, Downham MA, Gardner PS, Webb JK, Weightman D: Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J 1978,1(6104):11\u201314.","journal-title":"Br Med J"},{"issue":"4","key":"498_CR6_498","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/adc.59.4.306","volume":"59","author":"JY Mok","year":"1984","unstructured":"Mok JY, Simpson H: Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy. Arch Dis Child 1984,59(4):306\u2013309.","journal-title":"Arch Dis Child"},{"issue":"4","key":"498_CR7_498","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/adc.67.4.482","volume":"67","author":"M Murray","year":"1992","unstructured":"Murray M, Webb MS, O'Callaghan C, Swarbrick AS, Milner AD: Respiratory status and allergy after bronchiolitis. Arch Dis Child 1992,67(4):482\u2013487.","journal-title":"Arch Dis Child"},{"issue":"4","key":"498_CR8_498","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/adc.76.4.315","volume":"76","author":"V Noble","year":"1997","unstructured":"Noble V, Murray M, Webb MS, Alexander J, Swarbrick AS, Milner AD: Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child 1997,76(4):315\u2013319.","journal-title":"Arch Dis Child"},{"issue":"5","key":"498_CR9_498","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","volume":"161","author":"N Sigurs","year":"2000","unstructured":"Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000,161(5):1501\u20131507.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"498_CR10_498","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","volume":"171","author":"N Sigurs","year":"2005","unstructured":"Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B: Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005,171(2):137\u2013141.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"498_CR11_498","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/10446670410001722131","volume":"11","author":"WV Kalina","year":"2004","unstructured":"Kalina WV, Gershwin LJ: Progress in defining the role of RSV in allergy and asthma: from clinical observations to animal models. Clin Dev Immunol 2004,11(2):113\u2013119.","journal-title":"Clin Dev Immunol"},{"issue":"10","key":"498_CR12_498","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1084\/jem.20020943","volume":"196","author":"FJ Culley","year":"2002","unstructured":"Culley FJ, Pollott J, Openshaw PJ: Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. Journal of Experimental Medicine 2002,196(10):1381\u20131386.","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"498_CR13_498","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.4049\/jimmunol.175.3.1876","volume":"175","author":"A Dakhama","year":"2005","unstructured":"Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, Takeda K, Gelfand EW: The Enhancement or Prevention of Airway Hyperresponsiveness during Reinfection with Respiratory Syncytial Virus Is Critically Dependent on the Age at First Infection and IL-13 Production. J Immunol 2005,175(3):1876\u20131883.","journal-title":"J Immunol"},{"key":"498_CR14_498","first-page":"227","volume":"2","author":"C Spearman","year":"1908","unstructured":"Spearman C: The Method of Right and Wrong Cases (constant stimuli) Without Gauss's Formulae. Brit J Psychol 1908, 2:227\u2013242.","journal-title":"Brit J Psychol"},{"key":"498_CR15_498","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G Karber","year":"1931","unstructured":"Karber G: Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch exp Path Pharmak 1931, 162:480\u2013483.","journal-title":"Arch exp Path Pharmak"},{"issue":"1","key":"498_CR16_498","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1465-9921-6-122","volume":"6","author":"D Becnel","year":"2005","unstructured":"Becnel D, You D, Erskin J, Dimina DM, Cormier SA: A role for airway remodeling during respiratory syncytial virus infection. Respir Res 2005,6(1):122.","journal-title":"Respir Res"},{"issue":"11","key":"498_CR17_498","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1086\/324429","volume":"184","author":"RSJ Peebles","year":"2001","unstructured":"Peebles RSJ, Hashimoto K, Collins RD, Jarzecka K, Furlong J, Mitchell DB, Sheller JR, Graham BS: Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges. J Infect Dis 2001,184(11):1374\u20131379.","journal-title":"J Infect Dis"},{"issue":"1","key":"498_CR18_498","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1152\/jappl.1991.70.1.375","volume":"70","author":"R Sorkness","year":"1991","unstructured":"Sorkness R, Lemanske RFJ, Castleman WL: Persistent airway hyperresponsiveness after neonatal viral bronchiolitis in rats. J Appl Physiol 1991,70(1):375\u2013383.","journal-title":"J Appl Physiol"},{"issue":"6 Pt 1","key":"498_CR19_498","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1164\/ajrccm.154.6.8970378","volume":"154","author":"EW Uhl","year":"1996","unstructured":"Uhl EW, Castleman WL, Sorkness RL, Busse WW, Lemanske RFJ, McAllister PK: Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med 1996,154(6 Pt 1):1834\u20131842.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"498_CR20_498","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1086\/315783","volume":"182","author":"RSJ Peebles","year":"2000","unstructured":"Peebles RSJ, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS: Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV. J Infect Dis 2000,182(3):671\u2013677.","journal-title":"J Infect Dis"},{"issue":"11","key":"498_CR21_498","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.4049\/jimmunol.169.11.6482","volume":"169","author":"C Taube","year":"2002","unstructured":"Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, Balhorn A, Donaldson DD, Dakhama A, Gelfand EW: The Role of IL-13 in Established Allergic Airway Disease. J Immunol 2002,169(11):6482\u20136489.","journal-title":"J Immunol"},{"issue":"1","key":"498_CR22_498","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00063198-200301000-00004","volume":"9","author":"M Wills-Karp","year":"2003","unstructured":"Wills-Karp M, Chiaramonte M: Interleukin-13 in asthma. Current Opinion in Pulmonary Medicine 2003,9(1):21\u201327.","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"8","key":"498_CR23_498","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","volume":"8","author":"DA Kuperman","year":"2002","unstructured":"Kuperman DA, Huang XZ, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, Erle DJ: Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nature Medicine 2002,8(8):885\u2013889.","journal-title":"Nature Medicine"},{"issue":"7","key":"498_CR24_498","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1164\/rccm.200308-1203OC","volume":"169","author":"J Schwarze","year":"2004","unstructured":"Schwarze J, O'Donnell DR, Rohwedder A, Openshaw PJ: Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004,169(7):801\u2013805.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"498_CR25_498","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","volume":"160","author":"JJ Peschon","year":"1998","unstructured":"Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM: TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998,160(2):943\u2013952.","journal-title":"J Immunol"},{"issue":"9","key":"498_CR26_498","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L","volume":"31","author":"T Hussell","year":"2001","unstructured":"Hussell T, Pennycook A, Openshaw PJM: Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. European Journal of Immunology 2001,31(9):2566\u20132573.","journal-title":"European Journal of Immunology"},{"issue":"11","key":"498_CR27_498","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK: Etanercept in children with polyarticular juvenile rheumatoid arthritis. New England Journal of Medicine 2000,342(11):763\u2013769.","journal-title":"New England Journal of Medicine"},{"issue":"9207","key":"498_CR28_498","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0140-6736(99)00442-0","volume":"355","author":"S Bell","year":"2000","unstructured":"Bell S, Kamm MA: Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet 2000,355(9207):858\u2013860.","journal-title":"Lancet"},{"issue":"5","key":"498_CR29_498","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.4049\/jimmunol.173.5.3408","volume":"173","author":"JA Rutigliano","year":"2004","unstructured":"Rutigliano JA, Graham BS: Prolonged Production of TNF-{alpha} Exacerbates Illness during Respiratory Syncytial Virus Infection. J Immunol 2004,173(5):3408\u20133417.","journal-title":"J Immunol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-7-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-7-107\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-7-107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-7-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T12:24:28Z","timestamp":1683548668000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-7-107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-7-107","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,7]]},"assertion":[{"value":"27 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"107"}}